COVend partners at EMBL Conference, EMBO Workshop: Building Networks 2024 in Barcelona, Spain

COVend partners at EMBL Conference, EMBO Workshop: Building Networks 2024 in Barcelona, Spain The EMBL Conference, EMBO Workshop: Building Networks 2024 took place in Barcelona, Spain on May 6-8, bringing together researchers, scientists, and experts in the field of vascular biology. The event aimed to foster collaboration, share cutting-edge research, and advance our understanding of […]

Major Milestone Reached: COVend’s IXION 2.0 trial enrols its first patients!

We are excited to announce the start of patient enrollment for the IXION 2.0 clinical trial at the Goethe University Hospital Frankfurt. Due to the evolving dynamics of COVID-19, the project’s focus has shifted to investigating the potential benefits of the FX06 drug for patients with acute respiratory distress syndrome (ARDS). Spearheaded by Prof. Zacharowski and Dr. Petra Wülfroth, the co-founder of F4 Pharma in Vienna, the consortium and clinical trial were restructured in record time, underlining the unwavering joint commitment to innovative medical research in critical health conditions.

Groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome: FX06 is Pioneering New Frontiers in Clarkson Disease Treatment

Our COVend consortium member F4 Pharma’s cooperation partners presented groundbreaking research on Idiopathic Systemic Capillary Leak Syndrome (ISCLS), also known as Clarkson disease, first at the 124° Congresso Nazionale of the Societa Italiana di Medicina Interna (SIMI) in October 2023. Now their paper is officially published in Biomedicine & Pharmacotherapy.

COVend presented at ISPOR Europe 2023

On the 13th of November, the consortium member of our partner institution UMCG, Clazinus Veijer, presented his poster “Lessons learned from model-based economic evaluations of COVID-19 treatments under pandemic circumstances: results from a systematic review ” at ISPOR Europe 2023. The poster highlighted results from a systematic review of various methodological characteristics of model-based economic evaluations of COVID-19 treatments.

COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19

COVend Partners at University College Dublin Uncover Unique Cytokine Response in COVID-19 In the ongoing fight against COVID-19, COVend is dedicated to pushing the boundaries of scientific knowledge. Together with our partners at University College Dublin and Systems Biology Ireland, including Günther Eißner, Zhiran Wang, Vadim Zhernovkov, and Dmitrii Lebedev, we are delving into the […]

COVend and UN SDGs: Contributing to Shaping a Healthier World

image depicting two SDG icons

In 2015, the United Nations adopted the 17 Sustainable Development Goals (SDGs) as a global blueprint for addressing pressing challenges. These goals guide our efforts to combat poverty, inequality, climate change, and environmental concerns. Among them, two pivotal goals stand out – SDG 3: Good Health and Well-being, and SDG 9: Industry, Innovation and Infrastructure.

New Findings on FX06 and its Therapeutic Potential from the COVend Research Teams

image depicting a loudspeaker and the announcement "Big news for the COVend project"

What do an economist, a biochemist, and a clinician have in common? As it turns out, they can all benefit from the latest findings on FX06. The researchers from University College Dublin and the University Medical Center Groningen, the esteemed COVend consortium partners, have revealed new information on FX06 and its potential role in addressing hyperinflammation and capillary leak.

COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives”

image depicting the abstract and the QR-code to the COVend publication

COVend publication: “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” We are thrilled to announce the publication of “Reperfusion Injury: Mechanisms, Interventions, and Clinical Perspectives” by our esteemed partners Jan Kloka, Benjamin Friedrichson, Petra Wuelfroth, Rainer Henning, and Kai Zacharowski! This groundbreaking research delves into the complexities of reperfusion injury and offers valuable insights into potential […]

Highway to Health – The future of Healthcare in Europe

Highway to Health – the future of Healthcare in Europe COVend & ENVISION Cluster and Policy Event On 4 July 2023 the two project consortia of COVend and ENVISION, held a joint Cluster and Policy Event at the Representation of the State of Hesse to the EU in Brussels, Belgium, bringing together policymakers, health authorities, […]